31 Dec 2018 07:00
RNS Number : 7757L
Croda International PLC
31 December 2018
Croda International Plc ("Croda")
Acquisition of leading global vaccine adjuvant specialist
Further to the announcement on 17 December 2018, Croda has now completed the acquisition of Brenntag Biosector A/S ('Biosector') from Brenntag Nordic A/S on 28 December 2018. Biosector is a specialist in the manufacture and supply of adjuvants serving both the human and veterinary vaccine markets.
-ENDS-
For enquiries contact:
Investors: | Conleth Campbell, VP Investor Relations, Croda | +44 1405 860551 |
Press: | Charlie Armitstead, Teneo | +44 7703 330269 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Croda International (CRDA)